Skip to main navigation Skip to search Skip to main content

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia

  • Irene Bighelli
  • , Myrto T. Samara
  • , Alessandro Rodolico
  • , Wulf Peter Hansen
  • , Stefan Leucht
  • Technical University of Munich
  • University of Catania Medical School
  • BASTA – das Bündnis für Psychisch Erkrankte Menschen
  • School of Medicine

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects and safety of reducing antipsychotic dose compared to continuing the dose for people with schizophrenia. To examine factors of dose reduction such as its degree and rapidity.

Original languageEnglish
Article numberCD014384
JournalCochrane Database of Systematic Reviews
Volume2021
Issue number4
DOIs
StatePublished - 21 Apr 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Antipsychotic dose reduction compared to dose continuation for people with schizophrenia'. Together they form a unique fingerprint.

Cite this